Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Study analyzes self-reported long COVID symptoms through a healthcare app, revealing that symptom severity significantly varies by demographic factors such as age, gender, race, education, and socioeconomic status.

Pharma manufacturing M&A low in H1 2023 but high-value deals in demand for top CMOs – Pharmaceutical Technology

Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed 9 June 2023). © GlobalData. Note: Includes CMO deals related to asset (facility) acquisitions, company acquisition, and

June 28, 2023

J&J and Legend’s Carvykti scores early line approval for MM by FDA

Share this article J&J and Legend Biotech’s Carvykti is a B-cell maturation antigen (BCMA) directed CAR-T cell therapy. Image Credit: Corona Borealis Studio / Shutterstock.

April 8, 2024

AstraZeneca-Daiichi Sankyo’s gastric cancer therapy approved

AstraZeneca and Daiichi Sankyo’s Enhertu achieved a confirmed ORR of 28.8% and a median PFS of 5.7 months. Credit: Robert Way/Shutterstock. AstraZeneca and Daiichi Sankyo‘s

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.